C12N 2795/18123
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2795/18123 (Virus like particles [vlp]) appears on 41 US grants and 92 published applications in this corpus.
Search patents in C12N- Granted patents
- 41
- Published applications
- 92
- Assignees
- 36
- Inventors
- 133
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 2 |
| 2005 | 1 | 1 |
| 2006 | 2 | 3 |
| 2007 | 0 | 3 |
| 2008 | 1 | 2 |
| 2009 | 2 | 3 |
| 2010 | 0 | 7 |
| 2011 | 2 | 7 |
| 2012 | 1 | 3 |
| 2013 | 3 | 3 |
| 2014 | 0 | 4 |
| 2015 | 1 | 2 |
| 2016 | 1 | 5 |
| 2017 | 4 | 2 |
| 2018 | 3 | 5 |
| 2019 | 4 | 5 |
| 2020 | 1 | 2 |
| 2021 | 1 | 4 |
| 2022 | 1 | 6 |
| 2023 | 3 | 2 |
| 2024 | 4 | 6 |
| 2025 | 2 | 11 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for microbial delivery of double stranded RNA28 Jul 2026US 12,690,596 B2Rnaissance AG LLC
- Compositions and methods for tumor immunotherapy11 Mar 2025US 12,246,031 B2Checkmate Pharmaceuticals, Inc.
- HIV vaccine immunogens4 Mar 2025US 12,239,698 B2California Institute of Technology
- Malaria immunogen and methods for using same10 Dec 2024US 12,161,710 B2The Johns Hopkins University
- Compositions targeting apoptosis-associated speck-like protein with caspase activation and recruitment domain (ASC) and methods of use10 Dec 2024US 12,162,916 B2UNM Rainforest Innovations
- Methods and compositions for microbial delivery of double stranded rna8 Oct 2026US 2026/0305618 A1Rnaissance AG LLC
- Sialokinin immunogen and methods for using same13 Aug 2026US 2026/0234184 A1
- Malaria immunogen and methods of using same14 May 2026US 2026/0130979 A1UNM Rainforest Innovations
- S100a9 vaccines for cancer and atherosclerosis30 Oct 2025US 2025/0332234 A1The Regents of the University of California
- Multivalent display of apoai peptide on nanoparticles against atherosclerosis30 Oct 2025US 2025/0332278 A1The Regents of the University of California
Most cited
By later US patents
- Ribonuclease resistant RNA preparation and utilization80US 5,939,262 AAmbion, Inc. · 1999
- Hapten-carrier conjugates and uses thereof75US 6,932,971 B2Cytos Biotechnology AG · 2005
- Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use44US 7,517,520 B2Cytos Biotechnology AG · 2009
- Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity21US 8,574,564 B2Cytos Biotechnology AG · 2013
- Molecular antigen arrays17US 7,138,252 B2Cytos Biotechnology AG · 2006